The daily dose: October 27, 2021

# Covaxin saga continues: The Technical Advisory Group reviewing Covaxin will reconvene on November 3rd for the final risk-benefit assessment. And thi

Comments

Popular posts from this blog

Viral video involving woman cop sparks controversy, plaint filed

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar